ViraDx - to be scrapped after stocks run out
This to me seems dumb. Viradx was the bulk of the product revenue the last 12 months. Why now can it unless Febridx is taking off to replace the revenue they are obtaining?
Most companies listed have current position and projected fundamentals built into the price. LDX is only priced on current status and is has no future fundamentals built into the price. This is because the company simply doesn't guide on any of the information to determine the value of the deals.
Quoting total number of tests done a year and the reimbursement rate means f* all to most people.
If the future fundamentals of the company, i.e. FFN test being complete, CLIA waiver status, PHK test, Liver test etc was all built in, the price would be higher.
The fact this was priced at .10c average for a period of nearly 6-12 months until the capital raise indicated the fair value should have settled at that price without the Hologic FFN news etc.
There is no fundamental growth built into the share price as it stands today.
ViraDx - to be scrapped after stocks run out This to me seems...
Add to My Watchlist
What is My Watchlist?
